Neutralization of Variant Under Investigation B.1.617.1 With Sera of BBV152 Vaccinees
Open accessPublished version of a preprint
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
To the Editor—The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants in places where the virus is uncontained poses a global threat from the perspective of public health and vaccine efficacy. Peng et al [1] recently reported on the increased transmissibility with the newly emerged Variant of Concern (VOC) (20C/S:452R and 20C/S:452R) with the L452R mutation in San Francisco. We report the immunological characteristics of a Variant under Investigation (VUI) B.1.617.1, playing a critical role in the current surge of coronavirus disease 2019 (COVID-19) in the western state of Maharashtra, India. Several SARS-CoV-2 variants—B.1.1.7, B.1.351, and B.1.1.28.1—have been reported in India during 2021 [2, 3]. We had sequenced 146 nasopharyngeal/oropharyngeal swabs of COVID-19 cases [4]. Among these, 15 sequences had a combination of L452R and E484Q mutations, which raised concern as both are found in the receptor-binding domain (RBD) of the spike protein. However, the combined effect of these mutations is still unknown.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Starr, T. N., Greaney, A. J., Hilton, S. K., Ellis, D., Crawford, K. H. D., Dingens, A. S., Navarro, M. J., Bowen, J. E., Tortorici, M. A., Walls, A. C., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.012 · Cited by 1,956
Neutralizing Activity of BNT162b2-Elicited Serum
Liu, Y., Liu, J., Xia, H., Zhang, X., Fontes-Garfias, C. R., Swanson, K. A., Cai, H., Sarkar, R., Chen, W., Cutler, M., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmc2102017 · Cited by 537
Ella, R., Vadrevu, K. M., Jogdand, H., Prasad, S., Reddy, S., Sarangi, V., Ganneru, B., Sapkal, G., Yadav, P., Abraham, P., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30942-7 · Cited by 424
Self-citationTchesnokova, V., Kulasekara, H., Larson, L., Bowers, V., Rechkina, E., Kisiela, D., Sledneva, Y., Choudhury, D., Maslova, I., Deng, K., et al. (2021) · Journal of Clinical Microbiology · doi:10.1128/jcm.00921-21 · Cited by 217
Tchesnokova, V., Kulakesara, H., Larson, L., et al. (2021) · bioRxiv · doi:10.1101/2021.02.22.432189 · Cited by 154
Teng, S., Sobitan, A., Rhoades, R. E., Liu, D., & Tang, Q. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa233 · Cited by 125
Sapkal, G. N., Yadav, P. D., Ella, R., Deshpande, G. R., Sahay, R. R., Gupta, N., Vadrevu, K. M., Abraham, P., Panda, S., & Bhargava, B. (2021) · Journal of Travel Medicine · doi:10.1093/jtm/taab051 · Cited by 121
Self-citationFirst isolation of SARS-CoV-2 from clinical samples in India
Sarkale, P., Patil, S., Yadav, P. D., Nyayanit, D. A., Sapkal, G. N., Baradkar, S., Lakra, R., Shete-Aich, A., Prasad, S., Basu, A., et al. (2020) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_1029_20 · Cited by 112
Self-citationNeutralizing antibody responses to SARS-CoV-2 in COVID-19 patients
Deshpande, G. R., Sapkal, G. N., Tilekar, B. N., Yadav, P. D., Gurav, Y. K., Gaikwad, S., Kaushal, H., Deshpande, K., Kaduskar, O., Sarkale, P., et al. (2020) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_2382_20 · Cited by 77
Self-citationYadav, P. D., Nyayanit, D. A., Sahay, R. R., Sarkale, P., Pethani, J. D., Patil, S., Baradkar, S., Potdar, V. A., & Patil, D. Y. (2021) · Journal of Travel Medicine · doi:10.1093/jtm/taab009 · Cited by 45
Self-citation
Research works printed but not linked: 1
- Rambaut, Nat Microbiol
Cited by
Items 101–200 of 247
Fiolet, T., Kherabi, Y., MacDonald, C. J., Ghosn, J., & Peiffer‐Smadja, N. (2021) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/z4x7t · Cited by 22
From Alpha to Zeta: Identifying Variants and Subtypes of SARS-CoV-2 Via Clustering
Melnyk, A., Mohebbi, F., Knyazev, S., Sahoo, B., Hosseini, R., Skums, P., Zelikovsky, A., & Patterson, M. (2021) · Journal of Computational Biology · doi:10.1089/cmb.2021.0302 · Cited by 20
Molecular variants of SARS-CoV-2: antigenic properties and current vaccine efficacy
Damavandi, A. R., Dowran, R., Sharif, S. A., Kashanchi, F., & Jafari, R. (2022) · Medical Microbiology and Immunology · doi:10.1007/s00430-022-00729-6 · Cited by 23
van der Velden, Y. U., Grobben, M., Caniels, T. G., Burger, J. A., Poniman, M., Oomen, M., Rijnstra, E. S.-V., Tejjani, K., Guerra, D., Kempers, R., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-07590-w · Cited by 21
Jeda, A. S., Abbassi, S., Mousavizadeh, A., Esghaie, M., Bokharaei‐Salim, F., Jeddi, F., Shafaati, M., & Abdoli, A. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108232 · Cited by 26
Anwar, M. Z., Lodhi, M. S., Khan, M. T., Khan, M. I., & Sharif, S. (2022) · Genes · doi:10.3390/genes13030552 · Cited by 21
Sharma, S., Vercruysse, T., Sánchez-Felipe, L., Kerstens, W., Rasulova, M., Bervoets, L., Keyzer, C. D., Abdelnabi, R., Foo, C. S.-Y., Lemmens, V., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34439-7 · Cited by 27
Chiem, K., Vasquez, D. M., Silvas, J. A., Park, J., Piepenbrink, M. S., Sourimant, J., Lin, M. J., Greninger, A. L., Plemper, R. K., Torrelles, J. B., et al. (2021) · Journal of Virology · doi:10.1128/jvi.01126-21 · Cited by 19
Structural basis of nanobodies neutralizing SARS-CoV-2 variants
Shi, Z., Li, X., Wang, L., Sun, Z., Zhang, H., Chen, X., Cui, Q., Qiao, H., Lan, Z., Zhang, X., et al. (2022) · Structure · doi:10.1016/j.str.2022.02.011 · Cited by 19
Variantes de SARS-CoV-2, una historia todavía inacabada
Pérez-Abeledo, M., & Moreno, J. C. S. (2021) · Vacunas · doi:10.1016/j.vacun.2021.06.003 · Cited by 33
Chakravarty, N., Senthilnathan, T., Paiola, S. G., Gyani, P., Cario, S. C., Urena, E., Jeysankar, A., Jeysankar, P., Irudayam, J. I., Subramanian, S. N., et al. (2021) · FEBS Letters · doi:10.1002/1873-3468.14227 · Cited by 19
Bauer, G. (2022) · Exploration of Immunology · doi:10.37349/ei.2022.00040 · Cited by 19
Biological Significance of the Genomic Variation and Structural Dynamics of SARS-CoV-2 B.1.617
Fan, L.-Q., Hu, X.-Y., Chen, Y., Peng, X.-L., Fu, Y.-H., Zheng, Y.-P., Yu, J., & He, J. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.750725 · Cited by 19
Wu, X., Wang, Y., Cheng, L., Ni, F., Zhu, L., Ma, S., Huang, B., Ji, M., Hu, H., Li, Y., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.865401 · Cited by 18
Menasria, T., & Aguilera, J. (2022) · Microorganisms · doi:10.3390/microorganisms10020467 · Cited by 19
Rizwan, T., Kothidar, A., Meghwani, H., Sharma, V., Shobhawat, R., Saini, R., Vaishnav, H. K., Singh, V., Pratap, M., Sihag, H., et al. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.1944319 · Cited by 18
Implication of the emergence of the delta (B.1.617.2) variants on vaccine effectiveness
Al‐Tawfiq, J. A., Koritala, T., Alhumaid, S., Barry, M. A., Alshukairi, A. N., Temsah, M.-H. A., Mutair, A. S. A., Rabaan, A. A., Tirupathi, R., & Gautret, P. (2022) · Infection · doi:10.1007/s15010-022-01759-1 · Cited by 17
Ruiz, M. J., Siracusano, G., Cottignies-Calamarte, A., Tudor, D., Real, F., Zhu, A., Pastori, C., Capron, C., Rosenberg, A. R., Temperton, N. J., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.842468 · Cited by 22
Picazo, J. J. (2021) · Revista Española de Quimioterapia · doi:10.37201/req/085.2021 · Cited by 31
Focosi, D., Franchini, M., Joyner, M. J., & Casadevall, A. (2022) · Vox Sanguinis · doi:10.1111/vox.13239 · Cited by 17
Yadav, P. D., Mohandas, S., Sarkale, P., Nyayanit, D. A., Shete, A. M., Sahay, R. R., Potdar, V. A., Baradkar, S., Gupta, N., Sapkal, G. N., et al. (2021) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2021.12.009 · Cited by 17
Self-citationSingh, P., Ujjainiya, R., Prakash, S., Naushin, S., Sardana, V., Bhatheja, N., Singh, A. P., Barman, J., Kumar, K., Gayali, S., et al. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.105419 · Cited by 17
Self-citationZhao, S., Lou, J., Cao, L., Chong, K. C., Zee, B. C.-Y., Chan, P. K. S., & Wang, M. H. (2021) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2021.105162 · Cited by 16
Albreiki, M. S., Mousa, M., Azman, S. K., Vurivi, H., Alhalwachi, Z., Alshehhi, F., AlShamsi, S., Marzouqi, N. A., Alawadi, T., Alrand, H., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1049393 · Cited by 15
Patel, R. B., & Patel, B. B. (2022) · International Journal of Public Health · doi:10.3389/ijph.2022.1604975 · Cited by 20
Jahangir, M. A. (2021) · International Journal of Pharmaceutics & Pharmacology · doi:10.31531/2581-3080.1000153 · Cited by 13
Miteva, D., Kitanova, M., Batselova, H., Lazova, S., Chervenkov, L., Peshevska-Sekulovska, M., Sekulovski, M., Gulinac, M., Vasilev, G., Tomov, L., et al. (2023) · Vaccines · doi:10.3390/vaccines11071181 · Cited by 20
Kandeel, A., Moatasim, Y., Fahim, M., BahaaEldin, H., El‐Shesheny, R., Roshdy, W. H., Kamel, M. N., Shawky, S., Gomaa, M. R., Naguib, A. M., et al. (2023) · BMC Infectious Diseases · doi:10.1186/s12879-023-08527-y · Cited by 13
Notable and Emerging Variants of SARS-CoV-2 Virus: A Quick Glance
Dholariya, S. J., Parchwani, D. N., Singh, R., Sonagra, A. D., Motiani, A., & Patel, D. D. (2021) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-021-00991-0 · Cited by 14
Guo, M., Gao, M., Gao, J., Zhāng, T., Jin, X., Fan, J., Wang, Q., Li, X., Chen, J., & Zhu, Z. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.715023 · Cited by 15
Syndecan-4 Is a Key Facilitator of the SARS-CoV-2 Delta Variant’s Superior Transmission
Hudák, A., Veres, G., Letoha, A., Szilák, L., & Letoha, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020796 · Cited by 13
Izumi, H., Nafié, L. A., & Dukor, R. K. (2021) · ACS Omega · doi:10.1021/acsomega.1c03055 · Cited by 12
Kumar, A., Singh, N., & Joshi, R. (2023) · International Journal of Food Science & Technology · doi:10.1111/ijfs.16891 · Cited by 12
Kumar, A., Singh, N., & Joshi, R. (2024) · Cereal Chemistry · doi:10.1002/cche.10802 · Cited by 13
Antibody Cocktail Exhibits Broad Neutralization Activity Against SARS-CoV-2 and SARS-CoV-2 Variants
Qu, Y., Zhang, X., Wang, M., Sun, L., Jiang, Y., Li, C., Wu, W., Chen, Z., Yin, Q., Jiang, X., et al. (2021) · Virologica Sinica · doi:10.1007/s12250-021-00409-4 · Cited by 14
Chong, Z. X., Liew, W.-P.-P., Ong, H. K., Yong, C. Y., Shit, C. S., Ho, W. Y., Ng, S., & Yeap, S. K. (2021) · Pathology - Research and Practice · doi:10.1016/j.prp.2021.153565 · Cited by 14
SARS-CoV-2 variants, a still unfinished story
Pérez-Abeledo, M., & Moreno, J. C. S. (2021) · Vacunas (English Edition) · doi:10.1016/j.vacune.2021.10.003 · Cited by 13
SARS-CoV-2 variants of concern: a review
Sarkar, M. S., & Madabhavi, I. (2022) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2022.2337 · Cited by 17
González-Puelma, J., Aldridge, J., de, M. M., Pinto, M., Uribe-Paredes, R., Fernández-Goycoolea, J., Álvarez-Saravia, D., Álvarez, H., Encina, G., Weitzel, T., et al. (2021) · Viruses · doi:10.3390/v13050883 · Cited by 14
SARS-CoV-2 Portrayed against HIV: Contrary Viral Strategies in Similar Disguise
Duerr, R., Crosse, K. M., Valero-Jimenez, A. M., & Dittmann, M. (2021) · Microorganisms · doi:10.3390/microorganisms9071389 · Cited by 13
Nucleocapsid Mutations R203K/G204R Increase the Infectivity, Fitness and Virulence of SARS-CoV-2Preprint
Wu, H., Xing, N., Meng, K., Fu, B., Xue, W., Dong, P., Tang, W., Xiao, Y., Liu, G., Luo, H., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3896432 · Cited by 12
Li, M., Chen, J., Liu, Y., Zhao, J., Li, Y., Hu, Y., Chen, Y.-Q., Sun, L., Shu, Y., Feng, F., et al. (2022) · Antiviral Research · doi:10.1016/j.antiviral.2022.105383 · Cited by 12
Kumar, A., Joshi, R., Awasthi, T., & Singh, N. (2023) · International Journal of Food Science & Technology · doi:10.1111/ijfs.16497 · Cited by 13
Chen, X., Chen, Z., Azman, A. S., Sun, R., Lu, W., Zheng, N., Zhou, J., Wu, Q., Deng, X., Zhao, Z., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3858816 · Cited by 12
The Perspective of Acquired Immunity to Combat against Infectious Diseases: An Overview
Islam, M. S., Chaudhuri, I., Mobin, M. A., Islam, M., Mahmud, M. S., KutubUddin, M., Kabir, K. M. A., & Kamrujjaman, M. (2021) · Health · doi:10.4236/health.2021.139077 · Cited by 12
Zhao, S., Wang, K., Chong, K. C., Musa, S. S., He, M., Han, L., He, D., & Wang, M. H. (2022) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2022.111105 · Cited by 10
Nelde, A., Rieth, J., Roerden, M., Dubbelaar, M. L., Gravel, N. H., Bauer, J., Klein, R., Hoheisel, T., Mahrhofer, H., Göpel, S., et al. (2022) · iScience · doi:10.1016/j.isci.2022.105643 · Cited by 11
Challenges of SARS-CoV-2 genomic surveillance in India during low positivity rate scenario
Tomar, S. S., & Khairnar, K. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1117602 · Cited by 10
Wang, J., Yang, Y., Liang, T., Yang, N., Li, T., Zheng, C. J., Ning, N., Luo, D., Yang, X., He, Z., et al. (2021) · Journal of Advanced Research · doi:10.1016/j.jare.2021.07.008 · Cited by 10
Corrao, G., Franchi, M., Rea, F., Cereda, D., Barone, A. A., Borriello, C. R., Valle, P. G. D., Ercolanoni, M., Fortino, I., Jara, J., et al. (2022) · BMC Medicine · doi:10.1186/s12916-022-02262-y · Cited by 10
Protective efficacy of COVAXIN® against Delta and Omicron variants in hamster model
Yadav, P. D., Mohandas, S., Shete, A. M., Sapkal, G. N., Deshpande, G. R., Kumar, A., Wakchaure, K., Dighe, H., Jain, R., Ganneru, B., et al. (2022) · iScience · doi:10.1016/j.isci.2022.105178 · Cited by 13
Self-citationTragni, V., Mercurio, I., Paoletti, D. P., Onofrio, A., Laera, L., Beltrame, L. C., Sgobba, M. N., Guerra, L., Volpicella, M., Grassi, A., et al. (2023) · Journal of Medical Virology · doi:10.1002/jmv.28875 · Cited by 10
Ramaiah, A., Khubbar, M. K., Akinyemi, K., Bauer, A., Carranza, F., Weiner, J., Bhattacharyya, S., Payne, D. J., & Balakrishnan, N. (2023) · Viruses · doi:10.3390/v15091940 · Cited by 8
Diverse vaccine platforms safeguarding against SARS-CoV-2 and its variants
Chatterjee, B., & Thakur, S. S. (2021) · Expert Review of Vaccines · doi:10.1080/14760584.2022.1997601 · Cited by 13
Chauhan, D., Chakravarty, N., Jeyachandran, A. V., Jayakarunakaran, A., Sinha, S., Mishra, R. K., Arumugaswami, V., & Ramaiah, A. (2022) · Viruses · doi:10.3390/v14112461 · Cited by 11
Al-Hatamleh, M. A. I., Abusalah, M. A. H., Hatmal, M. M., Alshaer, W., Ahmad, S., Mohd-Zahid, M. H., Rahman, E. N. S. E. A., Yean, C. Y., Alias, I. Z., Uskoković, V., et al. (2022) · Journal of Taibah University Medical Sciences · doi:10.1016/j.jtumed.2022.11.007 · Cited by 11
Zhang, L., Li, Q., Wu, J., Yu, Y., Zhang, Y., Nie, J., Liang, Z., Cui, Z., Liu, S., Wang, H., et al. (2022) · Emerging Microbes & Infections · doi:10.1080/22221751.2022.2054369 · Cited by 10
Sequence analysis of SARS-CoV-2 Delta variant isolated from Makassar, South Sulawesi, Indonesia
Massi, M. N., Sjahril, R., Halik, H., Soraya, G. V., Hidayah, N., Pratama, M. Y., Faruk, M., Handayani, I., Gazali, F. M., Hakim, M. S., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e13382 · Cited by 9
Kuzmina, A., Korovin, D., Cohen-Lass, I., Atari, N., Ottolenghi, A., Hu, P., Mandelboim, M., Rosental, B., Rosenberg, E., Diaz‐Griffero, F., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e16750 · Cited by 8
Alenquer, M., Ferreira, F., Lousa, D., Valério, M., Medina-Lopes, M., Bergman, M., Gonçalves, J., Demengeot, J., Leite, R. B., Lilue, J., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.22.441007 · Cited by 8
Covaxin (BBV152) Vaccine Neutralizes SARS-CoV-2 Delta and Omicron variantsPreprint
Edara, V. V., Patel, M., & Suthar, M. S. (2022) · medRxiv · doi:10.1101/2022.01.24.22269189 · Cited by 8
Deb, P., Molla, M. M. A., Saif‐Ur‐Rahman, K., Das, M. C., & Das, D. (2021) · Egyptian Journal of Bronchology · doi:10.1186/s43168-021-00090-x · Cited by 8
SARS-CoV-2 infection: a global outbreak and its implication on public health
Mohan, S., Anjum, M. R., Kodidasu, A., Prathyusha, T., Mrunalini, N. V., & Kishori, B. (2021) · Bulletin of the National Research Centre/Bulletin of the National Research Center · doi:10.1186/s42269-021-00599-7 · Cited by 7
Kumar, D., Antiya, S. P., Patel, S. S., Pandit, R. J., Joshi, M. N., Mishra, A. K., Joshi, C. G., & Patel, A. C. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192114391 · Cited by 7
COVID-19 Vaccines—All You Want to Know
Shishido, A. A., Barnes, A. H., Narayanan, S., & Chua, J. V. (2023) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0042-1759779 · Cited by 6
Zhao, S., Musa, S. S., Chong, K. C., Ran, J., Javanbakht, M., Han, L., Wang, K., Hussaini, N., Habib, A. G., Wang, M. H., et al. (2021) · Journal of Global Health · doi:10.7189/jogh.11.05028 · Cited by 7
Delta variant SARS-CoV-2 infections in pediatric cases during the second wave in India
Yadav, P. D., Kumar, G., Mukherjee, A., Nyayanit, D. A., Shete, A. M., Sahay, R. R., Kumar, A., Majumdar, T., Patil, S., Pandit, P., et al. (2022) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2022.06.001 · Cited by 8
Self-citationSharma, S., Vercruysse, T., Sánchez-Felipe, L., Kerstens, W., Rasulova, M., Abdelnabi, R., Foo, C. S.-Y., Lemmens, V., Looveren, D. V., Maes, P., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.11.12.468374 · Cited by 7
Hofman, P. M., Bordone, O., Chamorey, E., Benzaquen, J., Schiappa, R., Lespinet‐Fabre, V., Lantéri, E., Brest, P., Mograbi, B., Maniel, C., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.730577 · Cited by 7
Antibody multispecificity: A necessary evil?
Jaiswal, D., Verma, S., Nair, D. T., & Salunke, D. M. (2022) · Molecular Immunology · doi:10.1016/j.molimm.2022.10.012 · Cited by 6
Rey, F. A. (2021) · Comptes Rendus Biologies · doi:10.5802/crbiol.53 · Cited by 11
Shirato, K., Matsuyama, S., & Takeda, M. (2021) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.jjid.2021.213 · Cited by 6
Ghosh, A., Kar, P. K., Gautam, A., Gupta, R. K., Singh, R., Chakravarti, R., Ravichandiran, V., Dastidar, S. G., Ghosh, D., & Roy, S. (2022) · RSC Medicinal Chemistry · doi:10.1039/d2md00009a · Cited by 9
The Delta Variant Had Negligible Impact on COVID-19 Vaccine Effectiveness in the USAPreprint
Blaiszik, B. J., Graziani, C., Olds, J. L., & Foster, I. T. (2021) · medRxiv · doi:10.1101/2021.09.18.21263783 · Cited by 7
Khullar, N., Bhatti, J. S., Singh, S., Thukral, B., Reddy, P. H., & Bhatti, G. K. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i14.2064 · Cited by 6
Early detection of community acquired of SARS-CoV-2 lineage B.1.351 in Hong Kong
Tsang, A. K. L., Mak, G. C. K., Cheng, P. K. C., Yip, P. C. W., Ng, K. H. L., Lam, E. T. K., Chan, R. C. W., & Tsang, D. N. C. (2021) · Journal of Clinical Virology Plus · doi:10.1016/j.jcvp.2021.100029 · Cited by 5
Zhao, Q., Wang, C., Cheng, J., Yan, H., Wang, L., Da‐wei, Q., & Duan, J. (2022) · Journal of Analytical Methods in Chemistry · doi:10.1155/2022/2565494 · Cited by 5
What we know and don’t know on SARS-CoV-2 and COVID-19
Silva-Ayarza, I., & Bachelet, V. C. (2021) · Medwave · doi:10.5867/medwave.2021.04.8198 · Cited by 7
Kulus, J., Kulus, M., Stefańska, K., Sobolewski, J., Piotrowska‐Kempisty, H., Mozdziak, P. E., & Kempisty, B. (2021) · Vaccines · doi:10.3390/vaccines9060639 · Cited by 6
Emerging Mutations Potentially Related to SARS-CoV-2 Immune Escape: The Case of a Long-Term Patient
Capozzi, L., Simone, D., Bianco, A., Sambro, L. D., Rondinone, V., Pace, L., Manzulli, V., Iacobellis, M., & Parisi, A. (2021) · Life · doi:10.3390/life11111259 · Cited by 4
Muraoka, D., Moi, M. L., Muto, O., Nakatsukasa, T., Deng, S., Takashima, C., Yamaguchi, R., Sawada, S., Hayakawa, H., Nguyen, T. T. N., et al. (2024) · npj Vaccines · doi:10.1038/s41541-024-00961-6 · Cited by 4
SARS-CoV-2 tests in occupational settings: what you look for is what you get
Ferrari, L., Nigro, S., Bordini, L., Carugno, M., & Bollati, V. (2021) · La Medicina del Lavoro · doi:10.23749/mdl.v112i3.11472 · Cited by 4
COVID-19 VACCINES: EVIDENCE, CHALLENGES AND THE FUTURE
Tanzi, E., Genovese, C., Tettamanzi, M., Fappani, C., Raviglione, M. C., & Amendola, A. (2021) · Journal of preventive medicine and hygiene · doi:10.15167/2421-4248/jpmh2021.62.1s3.2084 · Cited by 6
Eldi, P., Cooper, T. H., Prow, N. A., Liu, L., Heinemann, G. K., Zhang, V. J., Trinidad, A. D., Guzman‐Genuino, R. M., Wulff, P., Hobbs, L., et al. (2022) · Immunology and Cell Biology · doi:10.1111/imcb.12539 · Cited by 6
Highly Networked SARS-CoV-2 Peptides Elicit T Cell Responses with Enhanced Specificity
Duette, G., Lee, E., Gomes, G. M. C., Tungatt, K., Doyle, C. M., Stylianou, V. V., Lee, A., Maddocks, S., Taylor, J., Khanna, R., et al. (2023) · ImmunoHorizons · doi:10.4049/immunohorizons.2300034 · Cited by 4
Epitope Analysis of Anti-SARS-CoV-2 Neutralizing Antibodies
Xue, J., & Tao, S. (2021) · Current Medical Science · doi:10.1007/s11596-021-2453-8 · Cited by 4
Caracterización genómica y variantes del virus SARS-CoV-2
Wong‐Chew, R. M., Ramírez, J. B. D., Velázquez, X. V., Maldonado, L. A. C., Osorno, Z. R. G., Medina, L. Á. P., Velázquez, I. O. R., Vilchis, H. J., Bautista, D. G., Martínez, E. E. M., et al. (2021) · Acta Médica Grupo Ángeles · doi:10.35366/101743 · Cited by 13
Alkhamis, M., Fountain-Jones, N. M., Khajah, M., Alghounaim, M., & Al-Sabah, S. (2022) · Virus Evolution · doi:10.1093/ve/veac040 · Cited by 4
SARS-CoV-2 Variants in Rhode Island; May 2022 Update.
Singh, M., Novitsky, V., Carpenter‐Azevedo, K., Howison, M., Huard, R. C., King, E., & Kantor, R. (2022) · PubMed · Cited by 4
Jabbour, G., Rego, S., Nguyenkhoa, V., & Dakshanamurthy, S. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.11.459907 · Cited by 4
The Mutational Landscape of SARS-CoV-2 Variants of Concern Recovered From Egyptian Patients in 2021
Seadawy, M. G., Binsuwaidan, R., Alotaibi, B. S., El-Masry, T. A., El-Harty, B. E., Gad, A. F., Elkhatib, W. F., & El-Bouseary, M. M. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.923137 · Cited by 3
A review of SARS-CoV-2 virology, vaccines, variants and their impact on the COVID-19 pandemic
Hirahata, T., Quraish, R. U., Quraish, A. U., & Quraish, S. U. (2024) · Reviews in Medical Microbiology · doi:10.1097/mrm.0000000000000393 · Cited by 5
Mane, A. K., Jain, S., Jain, A., Nema, V., Kurle, S. N., Saxena, V., Pereira, M., Sirsat, A., Pathak, G. N., Bhoi, V., et al. (2022) · Apmis · doi:10.1111/apm.13266 · Cited by 3
Self-citationMohammad, A., ALSHAWAF, E. M. M., Arefanian, H., Marafie, S. K., Khan, A., Wei, D., Al‐Mulla, F., & Abubaker, J. A. (2023) · Viruses · doi:10.3390/v15091907 · Cited by 4
Perez, J. C. (2021) · International Journal of Research -GRANTHAALAYAH · doi:10.29121/granthaalayah.v9.i6.2021.4039 · Cited by 3
Malhotra, S., Mani, K., Lodha, R., Bakhshi, S., Mathur, V. P., Gupta, P., Kedia, S., Sankar, J., Kumar, P., Kumar, A., et al. (2025) · The National Medical Journal of India · doi:10.25259/nmji_726_2022 · Cited by 3
SARS-CoV-2 Kappa Variant Shows Pathogenicity in a Syrian Hamster Model
Yadav, P., Mohandas, S., Shete, A., Nyayanit, D. A., Gupta, N., Patil, D., Sapkal, G., Potdar, V., Kadam, M., Kumar, A., et al. (2022) · Vector Borne and Zoonotic Diseases · doi:10.1089/vbz.2021.0080 · Cited by 3
Self-citationAshique, S., Kumar, S., Kumar, H., Roy, J., Pal, S., & Pal, S. (2023) · Indian Journal of Health Sciences and Biomedical Research · doi:10.4103/kleuhsj.kleuhsj_505_22 · Cited by 2
ACE2-Targeting Monoclonal Antibody as Potent and Broad-Spectrum Coronavirus BlockerPreprint
Chen, Y., Zhang, Y., Yan, R., Wang, G., Zhang, Y., Zhang, Z., Li, Y., Ou, J., Chu, W., Liang, Z., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.11.11.375972 · Cited by 3
Wilson, P. C., Changrob, S., Fu, Y., Guthmiller, J. J., Halfmann, P., Li, L., Stamper, C. T., Dugan, H. L., Accola, M. A., Rehrauer, W. M., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-678247/v1 · Cited by 3
Metadata
- Authors
- Yadav, P. D., Sapkal, G. N., Abraham, P., Ella, R., Deshpande, G., Patil, D. Y., Nyayanit, D. A., Gupta, N., Sahay, R. R., Shete, A. M., Panda, S., Bhargava, B., & Mohan, V. K.
- Affiliations
- ICMR-National Institute of Virology (IN)
- Bharat Biotech (India) (IN)
- Indian Council of Medical Research (IN)
- Corresponding author
- Yadav, Pragya D
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-05-07
- Volume
- 74
- Issue
- 2
- Pages
- 366-368
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W3159365602
- Cited by
- 251
- References
- 14
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 10 · 2023: 26 · 2022: 76 · 2021: 133
- FWCI
- 19.38
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- Locations
- Clinical Infectious Diseases (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Indian Council of Medical Research
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
- Keywords
- SARS-CoV-2, Omicron variant, L452R mutation, receptor binding domain, Maharashtra, COVID-19 pandemic, spike protein mutations
- MeSH terms
- Antibodies, Viral, Humans, Neutralization Tests, Antibodies, Neutralizing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.